Intensity Therapeutics Inc. (INTS)
(Delayed Data from NSDQ)
$0.28 USD
+0.01 (3.70%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $0.28 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Intensity Therapeutics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
INTS 0.28 +0.01(3.70%)
Will INTS be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for INTS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INTS
Is Cencora, Inc. (COR) Outperforming Other Medical Stocks This Year?
Has Cencora, Inc. (COR) Outpaced Other Medical Stocks This Year?
INTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for INTS
Crossed Above 50 Day Moving Average appears for INTS after 3.7% move
Is INTS preparing to trend higher? Crossed Above 50 Day Moving Average shows up after rocketing 8.15%
Is INTS primed for upward momentum? Crossed Above 20 Day Moving Average shows up after rallying 6.22%
Technical picture remains unchanged for INTS after it falls 1.1% on September 30
12 Health Care Stocks Moving In Wednesday's Pre-Market Session